Hosted on MSN2mon
Study: Statins Mitigate Heart Risks From JAK InhibitorsWASHINGTON -- Patients taking Janus kinase (JAK) inhibitors for rheumatoid arthritis (RA) may not have to worry so much about increased cardiovascular risk -- if they're taking statins ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback